Cancer & Disease Research
Filling a gap so biotech startups can advance to the next level
In the biotechnology industry, there is a need for capital among companies that are already commercial and have products with demonstrated success but that might not yet be profitable. BroadOak Capital fills the gap for biotech companies between venture capital and private equity, according to partner Bill Snider who spoke with ScienceBoard.net. Read More
Clinical trial optimization in CGT can help make cardiovascular therapies a reality
ScienceBoard.net caught up with Dr. Monica Shah, who is vice president of medical strategy and head of the Cell and Gene Therapy (CGT) Center of Excellence at IQVIA, at Meeting on the Mesa. Shah moderated "Personalizing Cardiovascular Therapies to Address the Underlying Causes of Disease" on day two of the meeting. Read More
Lessons learned help the cell and gene therapy industry deliver products to patients
On the second day of the Cell & Gene Meeting on the Mesa, Betty Woo, PhD, vice president and general manager of cell and gene therapy at Thermo Fisher Scientific, led a workshop titled "Industrialization of Cell Therapy Manufacturing -- Lessons Learned From Biologics." ScienceBoard.net caught up with Woo following the workshop. Read More
How can the cell and gene therapy field industrialize collaboration?
Adlai Goldberg, the global life sciences digital, social, and commercial innovation leader at Ernst & Young, led a workshop on "Unlocking the Power of Collaboration to Fuel the Industry Transformation for Cell and Gene Therapies" at the 2021 Cell & Gene Meeting on the Mesa. Goldberg called on the cell and gene therapy industry to adopt a mindset of co-collaboration. Read More
5 takeaways from the Cell & Gene Meeting on the Mesa
In this final episode of our coverage from the 2021 Cell & Gene Meeting on the Mesa, hosted by the Alliance for Regenerative Medicine, ScienceBoard.net Editor-in-Chief Samantha Black, PhD, discusses five takeaways from the event. Read More
Early engagement with regulatory agencies is key to therapeutic development
Next-generation advanced therapies call for novel regulatory approaches, according to Mark Lane, PhD, vice president, development consulting and scientific affairs, of Biopharma Excellence by PharmaLex. Lane moderated a panel discussion titled "Innovative Regulatory Pathways for Next-Generation Treatments" at the 2021 Cell & Gene Meeting on the Mesa. Read More
CGTBO editor comments on trends from Cell & Gene Meeting on the Mesa
Blake Middleton, editor of Cell & Gene Therapy Business Outlook (CGTBO), was joined by Bruce Carlson, senior vice president of publications at Science and Medicine Group, to review the latest developments in therapies from the 2021 Cell  & Gene Meeting on Mesa. Read More
Precision Advance aims to improve patient access to cell and gene therapy
Improving patient access to cell and gene therapy treatments is the goal of Precision Advance, an initiative of Precision Medicine Group. Precision Advance provides a set of interconnected services and personnel designed to help bring new therapies to market. Read More
Dialogue with regulators will help bring cell and gene therapies to market
CARLSBAD, CA - Open engagement and frequent communication with regulators is needed throughout the development process for cell and gene therapies to help bring them to market, according to an October 13 session at the Cell & Gene Meeting on the Mesa. Read More
Catching up with the Alliance for Regenerative Medicine at Cell & Gene Meeting on the Mesa
CARLSBAD, CA - What's going on at this week's Cell & Gene Meeting on the Mesa? ScienceBoard.net spoke with Stephen Majors, director of public affairs at the Alliance for Regenerative Medicine, who shared what's being discussed at this year's meeting. Read More
Conferences
Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter